Evidence map›Paper›PMID 36894572›Full record

ArticleScientific reports2023

A CAD system for automatic dysplasia grading on H&E cervical whole-slide images.

Sara P Oliveira, Diana Montezuma, Ana Moreira, Domingos Oliveira, Pedro C Neto, Ana Monteiro, João Monteiro, Liliana Ribeiro, Sofia Gonçalves, Isabel M Pinto and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 11 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Sara P Oliveira *INESCTEC, 4200-465, Porto, Portugal.
Diana Montezuma *IMP Diagnostics, 4150-146, Porto, Portugal. diana.felizardo@impdiagnostics.com.
Ana Moreira *FEUP, University of Porto, 4200-465, Porto, Portugal.
Domingos OliveiraIMP Diagnostics, 4150-146, Porto, Portugal.
Pedro C NetoINESCTEC, 4200-465, Porto, Portugal.
Ana MonteiroIMP Diagnostics, 4150-146, Porto, Portugal.
João MonteiroIMP Diagnostics, 4150-146, Porto, Portugal.
Liliana RibeiroIMP Diagnostics, 4150-146, Porto, Portugal.
Sofia GonçalvesIMP Diagnostics, 4150-146, Porto, Portugal.
Isabel M PintoIMP Diagnostics, 4150-146, Porto, Portugal.
Jaime S CardosoINESCTEC, 4200-465, Porto, Portugal.
INESC TEC · PTUniversidade do Porto · PTInstituto de Engenharia de Sistemas e Computadores Investigação e Desenvolvimento · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is the fourth most common female cancer worldwide and the fourth leading cause of cancer-related death in women. Nonetheless, it is also among the most successfully preventable and treatable types of cancer, provided it is early identified and properly managed. As such, the detection of pre-cancerous lesions is crucial. These lesions are detected in the squamous epithelium of the uterine cervix and are graded as low- or high-grade intraepithelial squamous lesions, known as LSIL and HSIL, respectively. Due to their complex nature, this classification can become very subjective. Therefore, the development of machine learning models, particularly directly on whole-slide images (WSI), can assist pathologists in this task. In this work, we propose a weakly-supervised methodology for grading cervical dysplasia, using different levels of training supervision, in an effort to gather a bigger dataset without the need of having all samples fully annotated. The framework comprises an epithelium segmentation step followed by a dysplasia classifier (non-neoplastic, LSIL, HSIL), making the slide assessment completely automatic, without the need for manual identification of epithelial areas. The proposed classification approach achieved a balanced accuracy of 71.07% and sensitivity of 72.18%, at the slide-level testing on 600 independent samples, which are publicly available upon reasonable request.

Indexed as

Carcinoma, Squamous CellSquamous Intraepithelial LesionsUterine Cervical DysplasiaUterine Cervical NeoplasmsCervix UteriFemaleHumansHyperplasiaNeoplasm Grading

Identifiers

PMID36894572
PMCPMC9998461
OpenAlexW4323807484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.